Urine, instead, is used in a new urine-based assay to detect single mutant molecules of fibroblast growth factor receptor 3 (FGFR3) that are indicative of bladder cancer, which represents a noninvasive tool of early-stage diagnosis [32]. Here, FGFR3 is linked to urinary bladder cancer.